Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PMP22 | Q01453 | 2/20 | 1.00 |
| ▸ | GCLC | P48506 | 1/20 | 0.50 |
| ▸ | GSR | P00390 | 2/20 | 0.46 |
| ▸ | GRM8 | O00222 | 1/20 | 0.46 |
| ▸ | GRM6 | O15303 | 1/20 | 0.46 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.46 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.46 |
| ▸ | GRM5 | P41594 | 1/20 | 0.46 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.46 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.46 |
| ▸ | GRIA3 | P42263 | 1/20 | 0.46 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.46 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.46 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.46 |
| ▸ | GRIA4 | P48058 | 1/20 | 0.46 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.46 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.46 |
| ▸ | GRIK2 | Q13002 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL187873 | 1.00 | PMP22 (1.00) | PMP22GCLCGSRGRM8GRM6 | |
| SCHEMBL8594079 | 1.00 | PMP22 (1.00) | PMP22GCLCGSRGRM8GRM6 | |
| SCHEMBL1347918 | 1.00 | PMP22 (1.00) | PMP22GCLCGSRGRM8GRM6 | |
| Ammonia Solution, Strong SCHEMBL16912221 | 0.98 | PMP22 (0.96) | PMP22GCLCGSRGRM8GRM6 | |
| Phosphoric Acid SCHEMBL4258425 | 0.92 | PMP22 (0.85) | PMP22GCLCGRM8GRM6GRM7 | |
| Glutamine SCHEMBL831562 | 0.89 | PMP22 (0.79) | PMP22GCLCGSRGRM8GRM6 | |
| SCHEMBL11582563 | 0.89 | PMP22 (0.79) | PMP22GCLCGSRGRM8GRM6 | |
| Methionine SCHEMBL8736510 | 0.88 | PMP22 (0.77) | PMP22GCLCGSRGRM8GRM6 | |
| Methionine Sulfoxide SCHEMBL829430 | 0.85 | PMP22 (0.72) | PMP22GCLCGSRGRM8GRM6 | |
| SCHEMBL10001779 | 0.83 | PMP22 (0.70) | PMP22GCLCNOS2SLC7A5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 5232 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4747627-A1 | METHODS AND SYSTEMS FOR PREDICTIVE CLASSIFICATION BY MASS SPECTROMETRY AND TRAINED LARGE SPECTRAL MODELS | Matterworks Inc (US) | 2026-05-27 | — | — | EP | claimed |
| EP-4747275-A1 | VECTORS INCORPORATING A COMBINATION OF PROMOTERS DRIVING SELECTABLE MARKER EXPRESSION | Amgen Inc. (US) | 2026-05-27 | — | — | EP | claimed |
| US-12570536-B2 | Ammonia synthesis methods and systems | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2026-03-10 | — | — | US | claimed |
| EP-4655404-A1 | GLUTAMINE SYNTHETASE MARKER FOR RECOMBINANT EXPRESSION | Shanghai Zhenge Biotechnology Co., Ltd. (CN) | 2025-12-03 | — | — | EP | claimed |
| US-20250332141-A1 | A PHARMACEUTICAL COMPOSITION COMPRISING AN INHIBITOR OF GLUTAMINE SYNTHETASE ENZYME TO COMBAT ARTEMISININ RESISTANCE IN MALARIA | INSTITUTE OF LIFE SCIENCES (IN) | 2025-10-30 | — | — | US | claimed |
| WO-2025202830-A1 | METHOD FOR ENHANCING PRODUCTIVITY OF CLONES EXPRESSING PEMBROLIZUMAB | INTAS PHARMACEUTICALS LTD. (IN) | 2025-10-02 | — | — | WO | claimed |
| US-20250129127-A1 | Systems for Amplification of AAV Rep and Cap Proteins | SHAPE THERAPEUTICS INC. | 2025-04-24 | — | — | US | claimed |
| US-20250115666-A1 | CELL CULTURE METHODS FOR PRODUCING THERAPEUTIC PROTEINS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2025-04-10 | — | — | US | claimed |
| US-20250101402-A1 | SELECTABLE MARKERS FOR EUKARYOTIC EXPRESSION SYSTEM | SHANGHAI ZHENGE BIOTECHNOLOGY CO., LTD. (CN) | 2025-03-27 | — | — | US | claimed |
| US-20250066491-A1 | NOVEL MARKERS FOR RECOMBINANT PRODUCTION SYSTEM | SHANGHAI ZHENGE BIOTECHNOLOGY CO., LTD. (CN) | 2025-02-27 | — | — | US | claimed |
| US-5757408-A | PRINTING IMAGE ON SUBSTRATE COATED WITH AMINO-ACID DERIVATIVE ADDITIVE; QUICK DRYING OF INK, OPTICAL DENSITY, NONCURLING | XEROX CORPORATION (US) | 1998-05-26 | — | — | US | claimed |
| EP-0824919-A2 | Therapeutic methods and compositions for use therein | Holt, John Alfred Gorton (AU) | 1998-02-25 | — | — | EP | claimed |
| US-5683793-A | Ink jet transparencies | XEROX CORPORATION (US) | 1997-11-04 | — | — | US | claimed |
| US-5589277-A | INK JET PRINTING, AQUEOUS INKS, FAST DRYING | XEROX CORPORATION (US) | 1996-12-31 | — | — | US | claimed |
| US-5545819-A | TRANSFORMED CELLS AND PLANTS NOT ONLY TOLERATE GLUTAMINE SYNTHETASE INHIBITORS BUT ARE EFFECTIVELY STIIMULATED BY SUCH HERBICIDES | HOECHST AKTIENGESELLSCHAFT (DE) | 1996-08-13 | — | — | US | claimed |
| EP-0531031-B1 | Compositions for use in cancer therapy | HOLT JOHN ALFRED GORTON (AU) | 1995-11-02 | — | — | EP | claimed |
| EP-0667246-A1 | Recording sheets containing amino acids, hydroxy acids, and polycarboxyl compounds | XEROX CORPORATION (US) | 1995-08-16 | — | — | EP | claimed |
| EP-0531031-A1 | Compositions for use in cancer therapy | Holt, John Alfred Gorton (AU) | 1993-03-10 | — | — | EP | claimed |
| US-4659670-A | Biological desulfurization of coal | THE STANDARD OIL COMPANY | 1987-04-21 | — | — | US | claimed |
| EP-0126443-A2 | A process for the selective preparation of microorganisms capable of reproducible reduction of sulfur and use of the microorganism for microbial desulfurization of coal | THE STANDARD OIL COMPANY (US) | 1984-11-28 | — | — | EP | claimed |